Back to dashboard
MedicaidBilling CodesHigh impact

20-893 Updates to the Injectable Medication HCPCS/DOFR Crosswalk Reference Table - 4th Quarter 2020

Health Net·CA · Oncology, Hematology, Endocrinology +4 more·Prior Authorization
Effective date
Jan 21, 2021
We identified it
Jun 20, 2026
Days to comply

Summary

Health Net updated their injectable medication HCPCS/DOFR crosswalk reference table with 12 new injectable medications and 26 code updates/changes. The billing team must update their systems to reflect new HCPCS codes for recently approved medications and remove discontinued medications from their billing options.

Action Required

Action needed
By January 21, 2021: Billing team must update billing system with 12 new injectable medication HCPCS codes (including C9399 for Blenrep, J9145 for Darzalex, J0517 for Fasenra pen, etc.) and remove 15 discontinued medications from billing options (including Bayhep b, Bayrho-d, Baytet, Delatestryl variations). Update encounter forms and drug lists to reflect these changes. Verify DOFR categories for therapeutic injections vs self-injections to ensure proper billing.

Affected Billing Codes

C9399
J9145
J0517
J3590
J3490
J9227
J9999
90685
90687
J7196
90371
90385
J2788
J2790
J1670
J0490
J3120
J3121
J3130
J0886
J3111
90662
90694
J7192
J7190
J7194
Q5105
Q5106
J7197
J3032
J1632